Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart

Journal of Surgical Research

Volumn 201, Issue 2, 2016, Pages 272-278

  Charan, Kali ^a   Goyal, Ahsas ^a   Gupta, Jeetendra Kumar ^a   Yadav, Harlokesh Narayan ^b  

^a GLA UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Atrial natriuretic peptide; Diabetes; Ischemic preconditioning; Nitric oxide

Indexed keywords

ALLOXAN; ATRIAL NATRIURETIC FACTOR; CREATINE KINASE MB; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; GLUCOSE; LACTATE DEHYDROGENASE; N NITRO LEVO ARGININE METHYL ESTER; NITRIC OXIDE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY EFFLUENT; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME RELEASE; GLUCOSE BLOOD LEVEL; HEART; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART PROTECTION; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; ISOLATED HEART; LACTATE DEHYDROGENASE BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; ANIMAL; CARDIAC MUSCLE; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; HEART INFARCTION PREVENTION; IN VITRO STUDY; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PRECLINICAL STUDY; WISTAR RAT;

ALLOXAN; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; IN VITRO TECHNIQUES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRITES; RATS, WISTAR;

EID: 84961167884     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.10.045     Document Type: Article

References (40)

1. C.J. Murray, and A.D. Lopez Alternative projection of mortality and disability by cause 1990-2020: global burden of disease study Lancet 349 1997 1498
2. E.J. Topol, R.M. Califf, M. Vandormael, and et al. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and angioplasty in myocardial infarction-6 study group Circulation 85 1992 2090
3. G.F. Baxter, and Z. Ebrahim Role of bradykinin in preconditioning and protection of ischemic myocardium Br J Pharmacol 135 2002 843
4. H.M. Piper, Y. Abdullah, and C. Schafer The first minute of reperfusion: a window of opportunity for cardioprotection Cardiovasc Res 61 2004 365
5. C.E. Murray, J.B. Jenning, and K.A. Reimer Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium Circulation 74 1986 1124
6. D. Stokoe, L.R. Stephen, T. Copeland, and et al. Dual role of phosphatidylinositol-3,4,5 triphosphate in the activation of protein kinase B Science 277 1997 567
7. K. Garg, H.N. Yadav, M. Singh, and P.L. Sharma Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart Indian J Pharmacol 42 2010 219
8. P. Ferdinandy, R. Schulz, and G.F. Baxter Interaction of cardiovascular risk factor with myocardial ischemia/reperfusion injury, preconditioning and postconditioning Pharmacol Rev 59 2007 418
9. M.G.M. Prendes, M. Gonzalez, E.A. Savino, and A. Varela Role of endogenous nitric oxide in classic preconditioning in rat heart Regul Pept 139 2007 141
10. P. Abete, N. Ferrara, A. Cioppa, and et al. Preconditioning does not prevent postischemic dysfunction in aging heart J Am Coll Cardiol 27 1996 1777
11. 2+ homeostasis in rat ventricular myocytes subjected to ischemic insult J Pharmacol Exp Ther 310 2004 606
12. L.H. Snoeckx, G.J. Der Vusse, W.A. Coumans, P.H. Willemsen, and R.S. Reneman Difference in ischemia tolerance between hypertrophied heart of adult and aged spontaneously hypertensive rats Cardiovasc Res 27 1993 874
13. L.H. Snoeckx, G.J. van der Vusse, W.A. Coumans, P.H. Willemsen, T. van der Nagel, and R.S. Reneman Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischemia Cardiovasc Res 20 1986 67
14. Z. Giricz, M.M. Lalu, C. Csonka, P. Bencsik, R. Schulz, and P. Ferdinandy Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition J Pharmacol Exp Ther 316 2006 154
15. H.N. Yadav, M. Singh, and P.L. Sharma Modulation of the cardio protective effect of ischemic preconditioning in hyperlipidaemic rat heart Eur J Pharmacol 643 2010 78
16. P. Ferdinandy, Z. Szilvassy, and G.F. Baxter Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci 19 1998 223
17. P. Ferdinandy Myocardial ischemia/reperfusion injury and preconditioning: effect of hypercholesterolaemia/hyperlipidaemia Br J Pharmacol 138 2003 283
18. ATP channels Cardiovasc Res 55 2003 642
19. H.N. Yadav, M. Singh, and P.L. Sharma Involvement of GSK-3β in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart Mol Cell Biochem 343 2010 75
20. W.J. Katon, E.Z.B. Lin, J. Russo, and et al. Cardiac risk factor in patient with diabetes mellitus and major depression J Gen Intern Med 19 2004 1192
21. J.R. Dietz Mechanisms of atrial natriuretic peptide secretion from the atrium Cardiovasc Res 68 2005 8
22. T. Nishikimi, N. Maeda, and H. Matsuoka The role of natriuretic peptide in cardioprotection Cardiovasc Res 69 2006 318
23. K. Sangwa, K. Nakanish, K. Ishino, M. Inoue, M. Kawada, and S. Sano Atrial natriuretic peptide protects against ischemic reperfusion injury in the isolated rat heart Ann Thorac Surg 77 2004 233
24. K.S. Murthy, B. Teng, J. Jin, and G.M. Makhlouf G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor Am J Physiol 275 1998 C1409
25. P. Ajmani, H.N. Yadav, M. Singh, and P.L. Sharma Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart BMC Cardiovasc Disord 11 2011 43
26. A. Jujic, P.M. Nilson, G. Engstrom, B. Hedblad, O. Melander, and M. Magnusson Atrial natriuretic peptide and type 2 diabetes development-biomarker and genotype association study PLoS One 9 2014 e89201
27. A.L. Birkenfeld, M. Boschmann, S. Engeli, and et al. Atrial natriuretic peptide and adiponectin interaction in man PLoS One 7 2012 e43238
28. V.K. Sharma, S. Kumar, H.J. Patel, and S. Hugar Hypoglycemic activity of Ficus glomerata in alloxan induced diabetic rats Int J Pharm Sci Rev Res 1 2010 18
29. O. Langendorff Untersuchungen am uberlebenden saugethierherzen Pflugers Arch 61 1895 291
30. M. Skrzypie-spring, B. Grotthus, A. Szelag, and R. Schulz Isolated heart perfusion according to Langendorff - still viable in the new millennium J Pharmacol Toxicol Methods 55 2007 113
31. M.C. Fishbein, S. Meerbaum, J. Rit, and et al. Early phase of acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique Am Heart J 101 1981 593
32. K. Chopra, M. Singh, N. Kaul, K.L. Andrabi, and N.K. Ganguly Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect Mol Cell Biochem 113 1992 71
33. M.A. Marletta, P.S. Yoon, R. Lyenger, C.D. Leaf, and J.S. Wishnok Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate Biochemistry 27 1988 8706
34. C. Szabo, C. Thiemermann, and J.R. Vane Dihydropyridine modulators of calcium channel inhibit the induction of nitric oxide synthase by endotoxin in cultured J77.2 cells Biochem Biophys Res Commun 196 1993 825
35. C. Szabo, C.C. Wu, J.A. Mitchell, S.S. Gross, C. Thiemermann, and J.R. Vane Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide Circ Res 73 1993 991
36. V. Parikh, and M. Singh Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischemic preconditioning Mol Cell Biochem 199 1999 1
37. K. Ichinose, E. Kawasaki, and K. Eguchi Recent advancement of understanding pathogenesis of type-1 diabetes and potential relevance to diabetic nephropathy Am J Nephrol 27 2007 554
38. Z. Yang, Y. Tian, Y. Liu, S. Hennessy, I.L. Kron, and B.A. French Acute hyperglycemic abolishes ischemic preconditioning by inhibiting Akt phosphorylation: normalizing blood glucose before ischemia restore ischemic preconditioning Oxid Med Cell Longev 2013 2013 8 Article ID 329183
39. A. Hampel, M. Friedrich, K.D. Schluter, W.G. Forssmann, M. Kuhn, and H.M. Piper ANP protects against deoxygenating induced hypercontracture in adult cardiomyocytes Am J Physiol 273 1997 H244
40. X.M. Yang, S. Philip, J.M. Doweny, and M.V. Cohen Atrial natriuretic peptide administration just prior to reperfusion limits infarction in rabbit heart Basic Res Cardiol 101 2006 311